Publications by authors named "Fu-lan Yang"

Claim this Profile
B
Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases.
Xun Xi, Xing-Wei Huang, Huo-Zhong Yuan, Chun He, Jun Ni, Fu-Lan Yang

Oncol Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
Jun Ni, Yun Peng, Fu-Lan Yang, Xun Xi, Xing-Wei Huang

Onco Targets Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML Cells.
Fu-Lan Yang, Fang-Zhi Chen, Xin-Xing Wan, Xi Zhou, Mei-Juan Zhou

Biomed Res Int· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ISG15 inhibits IFN-α-resistant liver cancer cell growth.
Xin-xing Wan, Han-chun Chen, Md Asaduzzaman Khan, Ai-hua Xu, Fu-lan Yang

Biomed Res Int· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population.
Fang-dan Ouyang, Fu-lan Yang, Han-chun Chen, Md Asaduzzaman Khan, Feng-mao Huang

Tumour Biol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Feng-mao Huang, Han-chun Chen, Md Asaduzzaman Khan, Fu-lan Yang, Xin-xing Wan, Fang-dan Ou-yang

Med Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis